on Evotec AG (NASDAQ:EVTCY)
Evotec SE to Release 2025 Financial Results
Evotec SE announced it will disclose its financial results for the fourth quarter and full-year 2025 on April 8, 2026. The life science company plans to hold a webcast and conference call to discuss the results in detail. Scheduled for 2:00 pm CEST, the event will offer insights into the company's financial performance and business outlook.
Participants are encouraged to register in advance to access the live event, presentation slides, and later, the on-demand version on Evotec's official website. The company, listed on NASDAQ and Frankfurt Prime Standard, is recognized for its innovative contributions in drug discovery and development.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Evotec AG news